Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the GWTG-HF Registry

BACKGROUND: In clinical trials, hydralazine-isosorbide dinitrate (H-ISDN) for heart failure with reduced ejection fraction reduced morbidity and mortality among black patients and patients with intolerance to angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs)....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Heart Fail
Main Authors: Khazanie, Prateeti, Liang, Li, Curtis, Lesley H., Butler, Javed, Eapen, Zubin J., Heidenreich, Paul A., Bhatt, Deepak L., Peterson, Eric D., Yancy, Clyde W., Fonarow, Gregg C., Hernandez, Adrian F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4755330/
https://ncbi.nlm.nih.gov/pubmed/26867758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.115.002444
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados